NUMB attenuates posttraumatic osteoarthritis by inhibiting BTRC and inactivating the NF-κB pathway

Lv Zhou, Ding Yuan, Yaoguang ZhangJournal of Orthopaedic Surgery and Research 2024 · DOI

Abstract

Posttraumatic osteoarthritis (PTOA) is a degenerative joint condition driven by inflammatory responses following mechanical injury. This study investigates the role of the protein NUMB in PTOA progression using rat models and human chondrocyte cultures. We found that NUMB expression is significantly reduced in PTOA conditions. Overexpression of NUMB was shown to enhance cell viability and reduce apoptosis, inflammation, and cartilage degradation. Mechanistically, NUMB binds to BTRC, preventing the degradation of IκBα and thereby inactivating the NF-κB signaling pathway. These findings suggest that the NUMB/BTRC/NF-κB axis is a potential therapeutic target for treating PTOA.

Introduction

Posttraumatic osteoarthritis (PTOA) frequently follows acute joint injuries, such as ACL tears, and is characterized by a rapid inflammatory response that leads to cartilage breakdown. Unlike age-related osteoarthritis, PTOA often affects younger populations, making the search for disease-modifying treatments urgent. Central to this process is the activation of the NF-κB pathway, which triggers the release of degradative enzymes and inflammatory cytokines. This study identifies NUMB as a key regulator that can suppress this inflammatory cascade.

Methods

The researchers utilized two primary models:

  1. In Vivo: Anterior cruciate ligament transection (ACLT) was performed on Sprague-Dawley rats to induce PTOA. A NUMB-overexpression plasmid (pcDNA-NUMB) was administered via intra-articular injection.
  2. In Vitro: Human chondrocytes were treated with Interleukin-1β (IL-1β) to mimic the post-injury inflammatory environment.

Severity of cartilage damage was assessed using the Osteoarthritis Research Society International (OARSI) scoring system and histological staining (Safranin O-fast green and HE). Molecular mechanisms were explored using Co-immunoprecipitation (Co-IP) and Western blotting.

Key Results

Disease Progression and NUMB Expression

The study confirmed that NUMB levels are downregulated in both the ACLT rat model and IL-1β-stimulated chondrocytes. As the disease progressed in the ACLT model, the severity of cartilage damage increased significantly over time, as measured by OARSI scores.

Progression of OARSI scores in the PTOA model over six weeks.

NUMB Inhibits the NF-κB Pathway via BTRC

A critical discovery was the physical interaction between NUMB and BTRC. BTRC typically promotes the degradation of IκBα, an inhibitor of NF-κB. By binding to BTRC, NUMB stabilizes IκBα, keeping NF-κB (p65) inactive in the cytoplasm. This prevents the transcription of inflammatory genes.

Therapeutic Effects of NUMB Overexpression

In the rat model, intra-articular injection of pcDNA-NUMB significantly reduced OARSI scores and preserved cartilage structure. In cell cultures, NUMB overexpression:

  • Increased cell viability (MTT assay).
  • Reduced apoptosis (TUNEL assay).
  • Decreased levels of inflammatory cytokines (TNF-α, IL-1β, IL-6).
  • Reduced matrix-degrading enzymes (MMP13) while increasing structural proteins (COL2A1).

Discussion

The findings highlight the NUMB/BTRC/NF-κB axis as a fundamental regulatory mechanism in PTOA. By acting as a molecular brake on inflammation, NUMB offers a promising avenue for therapeutic intervention. Future research should focus on developing stable delivery methods for NUMB-based therapies and exploring potential interactions with other signaling pathways involved in joint health.

Conclusion

NUMB plays a protective role in PTOA by inhibiting BTRC and subsequently inactivating the NF-κB pathway. Restoring or enhancing NUMB activity could effectively mitigate cartilage degradation and inflammation following joint injury.

Summary updated

Abstract

Posttraumatic osteoarthritis (PTOA) is closely related to the inflammatory response caused by mechanical injury and leads to joint degeneration. Herein, we aimed to evaluate the role and underlying mechanism of NUMB in PTOA progression. Anterior cruciate ligament transection (ACLT)-induced rats and interleukin (IL)-1β-treated chondrocytes were used as in vivo and in vitro models of PTOA, respectively. The NUMB overexpression plasmid (pcDNA-NUMB) was administered by intra-articular injection to PTOA model rats, and safranin O-fast green staining, the Osteoarthritis Research Society International (OARSI) scoring system, and HE staining were used to evaluate the severity of cartilage damage. The secretion of inflammatory cytokines (TNF-α, IL-1β, and IL-6) and chondrocyte-specific markers (MMP13 and COL2A1) was detected via ELISA. Cell viability and apoptosis were evaluated by MTT and TUNEL assays. NUMB was expressed at lower levels in ACLT-induced PTOA rats and in IL-1β-treated chondrocytes than in control rats and cells. NUMB overexpression enhanced cell viability and reduced cell apoptosis, inflammation and cartilage degradation in chondrocytes stimulated by IL-1β. NUMB bound to BTRC to promote p-IκBα expression, resulting in NF-κB pathway inactivation. BTRC overexpression reversed the promoting effect of NUMB overexpression on cell viability and the inhibitory effects of NUMB overexpression on apoptosis, inflammation and cartilage degradation in IL-1β-induced chondrocytes. In addition, overexpression of NUMB alleviated articular cartilage damage by repressing inflammation and cartilage degradation in ACLT-induced PTOA rats. Our data indicated that NUMB regulated PTOA progression through the BTRC/NF-κB pathway, which may be a viable therapeutic target in PTOA.
BibTeX
@article{zhou2024numb,
  author = {Lv Zhou and Ding Yuan and Yaoguang Zhang},
  title = {{NUMB attenuates posttraumatic osteoarthritis by inhibiting BTRC and inactivating the NF-κB pathway}},
  journal = {Journal of Orthopaedic Surgery and Research},
  year = {2024},
  doi = {10.1186/s13018-024-04967-7},
}
Figure